Summary
Pfizer Inc. (PFE) has filed an 8-K report on October 29, 2024, to announce its financial results for the third quarter of 2024. The report primarily serves to furnish a press release detailing these results, which was issued on the same day. Investors should note that this filing is furnished, not filed, and therefore does not carry the same implications under Section 18 of the Exchange Act. The key financial performance indicators and strategic updates will be found within the press release itself, which is incorporated by reference into this filing.
Key Highlights
- 1Pfizer Inc. announced its third quarter 2024 financial results on October 29, 2024, via an 8-K filing.
- 2The filing includes a press release (Exhibit 99) containing the detailed financial performance for Q3 2024.
- 3Information furnished under Item 2.02 is provided for informational purposes and is not considered 'filed' under Section 18 of the Exchange Act.
- 4The press release is the primary source for understanding Pfizer's operational and financial condition for the quarter.
- 5The filing also includes the Cover Page Interactive Data File (Exhibit 104) in XBRL format.